{"id":"W4383481487","doi":"10.1080/13696998.2023.2234235","title":"Cost-effectiveness of tezepelumab in Canada for severe asthma","year":2023,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada); University of Alberta; AstraZeneca (Canada)","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Asthma; Cost–utility analysis; Exacerbation; Quality-adjusted life year; Cost-effectiveness analysis; Cost effectiveness; Incremental cost-effectiveness ratio; Cohort; Cost–benefit analysis; Emergency medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001053656,0.00007138753,0.0004438093,0.0001239827,0.00001328243,0.000002970447,0.0001278651,0.00008065999,0.0001001086],"category_scores_gemma":[0.0007087443,0.00005618197,0.0001225849,0.00009396198,0.00004135986,0.00004434019,0.00002506455,0.0001857983,0.000002173045],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004041153,"about_ca_system_score_gemma":0.006214436,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009753057,"about_ca_topic_score_gemma":0.05656416,"domain_scores_codex":[0.9989712,0.00004820336,0.0005097588,0.0000789807,0.0002348705,0.000156979],"domain_scores_gemma":[0.9987769,0.0005291075,0.0002143034,0.00008141983,0.00008569902,0.0003125675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007668634,0.000804587,0.3064657,0.00358239,0.0006258361,0.002483195,0.0003660422,0.009544369,0.0002613684,0.001029088,0.03138043,0.6357883],"study_design_scores_gemma":[0.02282293,0.00159132,0.8289033,0.002479889,0.0001227171,0.0008506851,0.003486249,0.01396853,0.001446046,0.0007799728,0.123216,0.0003323267],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977911,0.0001822724,0.00008659458,0.001180011,0.0004085393,0.0002264839,0.00002736704,0.000002727363,0.00009490547],"genre_scores_gemma":[0.9991292,0.000214476,0.00004876588,0.0003503819,0.0002133746,0.000003299425,0.000005608572,0.0000120358,0.00002283439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.635456,"threshold_uncertainty_score":0.9994194,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03029584279058423,"score_gpt":0.3078310479287403,"score_spread":0.277535205138156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}